Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 982368, 10 pages
http://dx.doi.org/10.1093/ecam/neq057
Original Article

Anti-Cancer Effects of Protein Extracts from Calvatia lilacina, Pleurotus ostreatus and Volvariella volvacea

1Graduate Institute of Biomedical and Biopharmaceutical Sciences, College of Life Sciences, National Chiayi University, A25-303 Room, Life Sciences Hall, 300 Syuefu Road, Chiayi 60004, Taiwan
2Graduate Institute of Food Science and Biopharmaceutics, National Chiayi University, Chiayi, Taiwan
3Department of Chemical Biology, National Pingtung University of Education, Pingtung, Taiwan
4Department of Biology, The University of Memphis, Memphis, TN, USA
5Department of Applied Chemistry, Chung Shan Medical University, Taichung, Taiwan

Received 16 September 2009; Accepted 20 April 2010

Copyright © 2011 Jin-Yi Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. R. S. Wolff, E. Wisbeck, M. L. L. Silveira, R. M. M. Gern, M. S. L. Pinho, and S. A. Furlan, “Antimicrobial and antineoplasic activity of Pleurotus ostreatus,” Applied Biochemistry and Biotechnology, vol. 151, no. 2-3, pp. 402–412, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. G. Tsay, K. T. Chung, C. H. Yeh, W. L. Chen, C. H. Chen, and M. H. Lin, “Calvatia lilacina protein-extract induces apoptosis through glutathione depletion in human colorectal carcinoma cells,” Journal of Agricultural and Food Chemistry, vol. 57, pp. 1579–1588, 2009. View at Google Scholar
  3. A. Jedinak and D. Sliva, “Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway,” International Journal of Oncology, vol. 33, pp. 1307–1313, 2008. View at Google Scholar
  4. I. Sarangi, D. Ghosh, S. K. Bhutia, S. K. Mallick, and T. K. Maiti, “Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans,” International Immunopharmacology, vol. 6, no. 8, pp. 1287–1297, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Sun and J. Liu, “Purification, structure and immunobiological activity of a water-soluble polysaccharide from the fruiting body of Pleurotus ostreatus,” Bioresource Technology, vol. 100, no. 2, pp. 983–986, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. Y.-H. Gu and G. Sivam, “Cytotoxic effect of oyster mushroom Pleurotus ostreatus on human androgen-independent prostate cancer PC-3 cells,” Journal of Medicinal Food, vol. 9, no. 2, pp. 196–204, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Lavi, D. Friesem, S. Geresh, Y. Hadar, and B. Schwartz, “An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induces anti-proliferative and pro-apoptotic effects on HT-29 colon cancer cells,” Cancer Letters, vol. 244, no. 1, pp. 61–70, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Shlyakhovenko, V. Kosak, and S. Olishevsky, “Application of DNA from mushroom Pleurotus ostreatus for cancer biotherapy: a pilot study,” Experimental Oncology, vol. 28, no. 2, pp. 132–135, 2006. View at Google Scholar · View at Scopus
  9. J. F. Lucke, “Student's t test and the glasgow coma scale,” Annals of Emergency Medicine, vol. 28, no. 4, pp. 408–413, 1996. View at Google Scholar · View at Scopus
  10. R. Sullivan, J. E. Smith, and N. J. Rowan, “Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine,” Perspectives in Biology and Medicine, vol. 49, no. 2, pp. 159–170, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Geethangili and Y. M. Tzeng, “Review of pharmacological effects of Antrodia camphorata and its bioactive compounds,” Evidence-Based Complementary and Alternative Medicine. View at Publisher · View at Google Scholar
  12. H. M. Lien, H. W. Lin, Y. J. Wang, L. C. Chen, D. Y. Yang, and Y. Y. Lai, “Inhibition of anchorage-independent proliferation and G0/G1 cell-cycle regulation in human colorectal carcinoma cells by 4,7-dimethoxy-5-methyl-l,3-benzodioxole isolated from the fruiting body of Antrodia camphorata,” Evidence-Based Complementary and Alternative Medicine. View at Publisher · View at Google Scholar
  13. F. Firenzuoli, L. Gori, and G. Lombardo, “The medicinal mushroom Agaricus blazei murrill: review of literature and pharmaco-toxicological problems,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 1, pp. 3–15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. O. Kim, D. O. Moon, J. M. Jung, W. S. Lee, Y. H. Choi, and G. Y. Kim, “Agaricus blazei extract induces apoptosis through ROS-dependent JNK activation involving the mitochondrial pathway and suppression of constitutive NF-κB in THP-1 cells,” Evidence-Based Complementary and Alternative Medicine. View at Publisher · View at Google Scholar
  15. M. Kawamura and H. Kasai, “Delayed cell cycle progression and apoptosis induced by hemicellulase-treated Agaricus blazei,” Evidence-Based Complementary and Alternative Medicine, vol. 4, no. 1, pp. 83–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Tong, F. Xia, K. Feng et al., “Structural characterization and in vitro antitumor activity of a novel polysaccharide isolated from the fruiting bodies of Pleurotus ostreatus,” Bioresource Technology, vol. 100, no. 4, pp. 1682–1686, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. J. Youn, J. K. Kim, S. Y. Park, Y. Kim, S. J. Kim, and J. S. Lee, “Chaga mushroom (Inonotus obliquus) induces G0/G1 arrest and apoptosis in human hepatoma HepG2 cells,” World Journal of Gastroenterology, vol. 14, pp. 511–517, 2008. View at Google Scholar
  18. T. A. Ajith and K. K. Janardhanan, “Indian medicinal mushrooms as a source of antioxidant and antitumor agents,” Journal of Clinical Biochemistry and Nutrition, vol. 40, no. 3, pp. 157–162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Bano, K. S. Srinivasan, and H. C. Srivastava, “Amino acid composition of the protein from a mushroom (Pleurotus sp.),” Applied Microbiology, vol. 11, pp. 184–187, 1963. View at Google Scholar
  20. T. Watanabe, “Antineoplastic activity of polysaccharides of Pleurotus ostreates,” Nippon Rinsho, vol. 27, no. 6, pp. 1759–1761, 1969. View at Google Scholar · View at Scopus
  21. H. Wang, J. Gao, and T. B. Ng, “A new lectin with highly potent antihepatoma and antisarcoma activities from the oyster mushroom Pleurotus ostreatus,” Biochemical and Biophysical Research Communications, vol. 275, no. 3, pp. 810–816, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Kishida, Y. Sone, and A. Misaki, “Purification of an antitumor-active, branched (1–3)-β-d-glucan from Volvariella volvacea, and elucidation of its fine structure,” Carbohydrate Research, vol. 193, no. C, pp. 227–239, 1989. View at Google Scholar · View at Scopus
  23. Y. Sone, S. Shibata, E. Kishida, and A. Misaki, “Alteration of beta-D-glucan from edible mushroom after injection into mouse peritoneal cavity,” Journal of Nutritional Science and Vitaminology, vol. 40, pp. 335–341, 1994. View at Google Scholar
  24. E. Kishida, C. Kinoshita, Y. Sone, and A. Misaki, “Structures and antitumor activities of polysaccharides isolated from mycelium of Volvariella volvacea,” Bioscience, Biotechnology, and Biochemistry, vol. 56, no. 8, pp. 1308–1309, 1992. View at Google Scholar · View at Scopus
  25. Q. B. She, T. B. Ng, and W. K. Liu, “A novel lectin with potent immunomodulatory activity isolated from both fruiting bodies and cultured mycelia of the edible mushroom Volvariella volvacea,” Biochemical and Biophysical Research Communications, vol. 247, pp. 106–111, 1998. View at Google Scholar
  26. S. C. W. Sze, J. C. K. Ho, and W. K. Liu, “Volvariella volvacea lectin activates mouse T lymphocytes by a calcium dependent pathway,” Journal of Cellular Biochemistry, vol. 92, no. 6, pp. 1193–1202, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. W.-K. Liua, J. C. K. Ho, and T.-B. Ng, “Suppression of cell cycle progression by a fungal lectin: activation of cyclin-dependent kinase inhibitors,” Biochemical Pharmacology, vol. 61, no. 1, pp. 33–37, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. W. R. Sellers and D. E. Fisher, “Apoptosis and cancer drug targeting,” Journal of Clinical Investigation, vol. 104, no. 12, pp. 1655–1661, 1999. View at Google Scholar · View at Scopus
  29. W. Q. Chen, W. Shen, and D. M. Shen, “The changes of ROS and mitochondria membrane potential in HepG2 cells on the pressure of cisplatin,” Zhonghua Gan Zang Bing Za Zhi, vol. 13, no. 7, pp. 531–533, 2005. View at Google Scholar · View at Scopus
  30. S. K. Sandur, H. Ichikawa, M. K. Pandey et al., “Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane),” Free Radical Biology and Medicine, vol. 43, no. 4, pp. 568–580, 2007. View at Publisher · View at Google Scholar · View at Scopus